Table 1 Commonly Used Clinical Guidelines
| Â | Europe, n (%) | Asia Pacific, n (%) | North America, n (%) | Latin America, n (%) | Africa Middle East, n (%) | Total (n = 77) |
|---|---|---|---|---|---|---|
AAAAI/ACAAI 2008 Practice Parameter Update: Allergy diagnostic testing [13] | 14 (18.2) | 16 (19.5) | 6 (7.8) | 7 (9.1) | 3 (3.9) | 46 (59.7) |
EAACI/GA2LEN 2007: Aspirin provocation tests for aspirin hypersensitivity [14] | 20 (26.0) | 3 (3.9) | 2 (2.6) | 5 (6.5) | 2 (2.6) | 32 (41.6) |
ENDA 2003 Guidelines: DPTs [15] | 21 (27.3) | 6 (7.8) | 1 (1.3) | 3 (3.9) | 1 (1.3) | 32 (41.6) |
ENDA 2006: Statement on penicillin skin testing [17] | 17 (22.1) | 4 (5.2) | 1 (1.3) | 4 (5.2) | 2 (2.6) | 28 (36.4) |
ENDA 2004 Guidelines: Non-immediate allergic reactions to beta-lactam antibiotics [18] | 19 (24.7) | 4 (5.2) | 1 (1.3) | 3 (3.9) | 1 (1.3) | 28 (36.4) |
ENDA 2003 Guidelines: Immediate allergic reactions to beta-lactam antibiotics [19] | 18 (23.4) | 4 (5.2) | 1 (1.3) | 3 (3.9) | 1 (1.3) | 27 (35.1) |
BSACI 2009 Guidelines: Management of drug allergy [16] | 12 (15.6) | 11 (14.3) | 0 (0.0) | 2 (2.6) | 1 (1.3) | 26 (33.8) |
ENDA 2005 Guidelines: Management of hypersensitivity to iodinated contrast media [20] | 18 (23.4) | 2 (2.6) | 1 (1.3) | 3 (3.9) | 1 (1.3) | 25 (32.5) |
AAAAI/ACAAI 1999 Practice Parameter: Drug hypersensitivity [21] | 6 (7.8) | 9 (11.7) | 3 (3.9) | 4 (5.2) | 3(3.9) | 25 (32.5) |
AAAAI/ACAAI 2006 Practice Parameter: Contact dermatitis [22] | 10 (13.0) | 3 (3.9) | 4 (5.2) | 4 (5.2) | 1 (1.3) | 22 (28.6) |
SFAR/ENDA 2005 Guidelines: Reducing the risk of anaphylaxis during anaesthesia [23] | 13 (16.9) | 4 (5.2) | 1 (1.3) | 2 (2.6) | 1 (1.3) | 21 (27.3) |
European Society of Contact Dermatitis 2001 Guidelines for the study of skin testing in investigating CADR [24] | 13 (16.9) | 3 (3.9) | 2 (2.6) | 1 (1.3) | 1 (1.3) | 20 (26.0) |
International Contact Dermatitis Research Group (ICDRG) 1970: Criteria for patch test reading [25] | 5 (6.5) | 5 (6.5) | 3 (3.9) | 3 (3.9) | 1 (1.3) | 17 (22.1) |
BSACI 2003 Guidelines: Suspected anaphylactic reactions associated with anaesthesia [26] | 4 (5.2) | 5 (6.5) | 0 (0.0) | 1 (1.3) | 0 (0.0) | 10 (13.0) |